Home > Healthcare > Medical Devices > Diagnostic Devices > Primary Care POC Diagnostics Market

Primary Care POC Diagnostics Market Size

  • Report ID: GMI7895
  • Published Date: Jan 2024
  • Report Format: PDF

Primary Care POC Diagnostics Market Size

Primary Care POC Diagnostics Market size was valued at USD 18.3 billion in 2023 and is estimated to expand at 7% CAGR from 2024 to 2032. Point-of-care (POC) diagnostics in primary care refer to medical tests or diagnostic procedures that are performed at or near the location wherein patient care is provided, typically in a primary care setting such as a doctor's office, clinic, or community health center.

 

The primary goal of POC diagnostics is to obtain rapid and accurate diagnostic information, enabling healthcare providers to make immediate decisions about patient care. The increasing incidence of infectious diseases and chronic conditions including cardiovascular diseases is one of the major factors driving the demand for primary care POC diagnostics market progress. For instance, according to the World Health Organization (WHO) report, in 2021, there were around 37.7 million individuals suffering with human immunodeficiency virus (HIV).

 

Furthermore, the growing prevalence of diabetes worldwide is a significant factor contributing to increasing point of care testing, which is estimated to account for over USD 78 billion by 2032, at home-care settings. Additionally, as per statistics, approximately 537 million adults were individuals suffering from diabetes in 2021. Diabetic foot ulcers and pressure ulcers are a common complication and are a major cause of hospital admissions in people with diabetes. Thus, this growing prevalence of diabetes is anticipated to boost demand of primary care POC diagnostics and thereby accelerate market expansion.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global primary care POC diagnostics industry was valued at USD 18.3 billion in 2023 and is estimated to reach USD 33.6 billion by 2032, owing to the increasing incidence of infectious diseases and chronic conditions including cardiovascular diseases.

The glucose monitoring segment garnered USD 4.5 billion revenue size in the year 2023, driven by the increasing adoption of portable, high convenience, and cost-effectiveness as well as rapid primary POC glucose tests.

U.S. primary care POC diagnostics market accounted for USD 6.9 billion revenue size in 2023 and is predicted to witness substantial growth through 2032, attributed to the increasing government initiatives towards chronic and infectious diseases.

Abbott Laboratories., Sysmex Corporation., ACON Laboratories, Inc., Siemens Healthineers AG., Becton, Dickinson, and Company, Nova Biomedical., BioMerieux SA, Bio-Rad Laboratories, Inc, HemoCue AB (Danaher Corporation)., Dexcom, Inc., HemoCue AB (Danaher Corporation) and Dragerwerk Ag & Co.

Primary Care POC Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 482
  • Countries covered: 22
  • Pages: 180
 Download Free Sample